Press Releases and Events

PRESS RELEASES

Press Release | September 6, 2022

New Long-Term Safety and Efficacy Data Presented with Paltusotine in Participants Living with Acromegaly

READ MORE
Press Release | September 2, 2022

New Long-Term Safety and Efficacy Data for Paltusotine to be Presented at CBEM

READ MORE
Press Release | August 12, 2022

Crinetics Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update

READ MORE
Press Release | August 10, 2022

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

READ MORE
Press Release | July 12, 2022

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

READ MORE
Press Release | July 12, 2022

Additional Analyses of CRN04894 Preclinical and Phase 1 Results to be Presented at the 10th International Congress of Neuroendocrinology

READ MORE
Press Release | June 10, 2022

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

READ MORE
Press Release | June 8, 2022

Crinetics Presents Clinical and Research Results at ENDO 2022

READ MORE
Press Release | June 7, 2022

Crinetics Pharmaceuticals to Participate in the JMP Securities Life Sciences Conference

READ MORE
Press Release | May 25, 2022

Crinetics Reports Top-line CRN04894 MAD Results from Phase 1 Study

READ MORE
13 / 24